Homeβ€ΊSearchβ€ΊThe Lancet Oncology

The Lancet Oncology

Elsevier Ltd Β· United Kingdom Β· Est. 1906

ISSN1470-2045eISSN1474-5488
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJR
96
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (3 more)+18
Total96
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
Publication speed: not measurable
publisher doesn’t disclose per-article submission dates β€” we never estimate
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
9.432
H-Indexi
512
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
10.225
Total Worksi
12,026
Total Citationsi
1,033,284
2yr Mean Citednessi
9.37
Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

The Lancet Oncology is a clinical oncology journal that publishes original research, reviews, comment, opinion, news, and commissions. It covers international issues relevant to clinical cancer specialties worldwide, aiming to advance clinical practice, advocate for health policy change, and address global oncology issues. The journal also fosters research in internal medicine, oncology, cancer, and text mining, and connects internal medicine research with gastroenterology.

AI-compiled from public web sources Β· verify on publisher page β†’

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1906
FrequencyMonthly
StatusActive (last: 2026)
Total Publications12,026
Publisher OrgElsevier BV
Visit Journal Website

Submission Info

Peer Reviewβ€”
Review Timeβ€”
Acceptance Rateβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes

Think.Check.Submit Compliance

6/12 Β· 50%
βœ…
Do you know the journal / publisher?
Elsevier Ltd
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1470-2045 / 1474-5488
βœ…
Indexed in a trusted database?
WoS, Scopus
❌
Peer review process documented?
N/A
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
❌
Plagiarism detection in place?
N/A
❌
Listed in DOAJ (verified OA)?
N/A
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
560
57k
2019
496
60k
2020
499
44k
2021
498
21k
2022
421
15k
2023
470
8.9k
2024
503
3.7k
2025
222
207
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

OncologyQ1

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Oncology

Research Topics (OpenAlex)

Lung Cancer Treatments and MutationsGlobal Cancer Incidence and ScreeningEconomic and Financial Impacts of CancerAdvances in Oncology and RadiotherapyCancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesProstate Cancer Treatment and ResearchCancer Genomics and DiagnosticsHealth Systems, Economic Evaluations, Quality of LifeColorectal Cancer Treatments and Studies

Frequently asked questions about The Lancet Oncology

Is The Lancet Oncology a predatory journal?

PubScope has no integrity flags on record for The Lancet Oncology: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of The Lancet Oncology?

The Lancet Oncology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 9.37.

Is The Lancet Oncology indexed in Scopus and Web of Science?

The Lancet Oncology is indexed in Web of Science, Scopus.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref